受强制性开放获取政策约束的文章 - Christophe LMJ Verlinde了解详情
已要求撤换的文章：4 篇
Design and synthesis of bis-carbamate analogs of cyclic bis-(3′-5′)-diguanylic acid (c-di-GMP) and the acyclic dimer PGPG
T Kline, SR Jackson, W Deng, CLMJ Verlinde, SI Miller
Nucleosides, Nucleotides and Nucleic Acids 27 (12), 1282-1300, 2008
强制性开放获取政策： US National Institutes of Health
负责上传的作者： SI Miller
Multivalent drug design and inhibition of cholera toxin by specific and transient protein–ligand interactions
J Liu, D Begley, DD Mitchell, CLMJ Verlinde, G Varani, E Fan
Chemical biology & drug design 71 (5), 408-419, 2008
强制性开放获取政策： US National Institutes of Health
负责上传的作者： E Fan, G Varani
The structure of the D3 domain of Plasmodium falciparum myosin tail interacting protein MTIP in complex with a nanobody
S Khamrui, S Turley, E Pardon, J Steyaert, E Fan, CLMJ Verlinde, ...
Molecular and biochemical parasitology, 2013
强制性开放获取政策： US National Institutes of Health, Research Foundation (Flanders)
负责上传的作者： WGJ Hol
Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads
MA Hulverson, R Choi, MC McCloskey, GR Whitman, KK Ojo, ...
ACS Infectious Diseases 7 (5), 1275-1282, 2021
强制性开放获取政策： Bill & Melinda Gates Foundation
负责上传的作者： WC Van Voorhis
可在其他位置公开访问的文章：52 篇
Genomic-scale prioritization of drug targets: the TDR Targets database
F Agüero, B Al-Lazikani, M Aslett, M Berriman, FS Buckner, RK Campbell, ...
Nature reviews Drug discovery 7 (11), 900-907, 2008
强制性开放获取政策： US National Institutes of Health
Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors
KK Ojo, ET Larson, KR Keyloun, LJ Castaneda, AE DeRocher, ...
Nature structural & molecular biology 17 (5), 602-607, 2010
强制性开放获取政策： US National Institutes of Health
Rational modification of a candidate cancer drug for use against Chagas disease
JM Kraus, CLMJ Verlinde, M Karimi, GI Lepesheva, MH Gelb, FS Buckner
Journal of medicinal chemistry 52 (6), 1639-1647, 2009
强制性开放获取政策： US National Institutes of Health
Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
RC Murphy, KK Ojo, ET Larson, A Castellanos-Gonzalez, BGK Perera, ...
ACS medicinal chemistry letters 1 (7), 331-335, 2010
强制性开放获取政策： US National Institutes of Health
Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discovery
JM Kraus, HB Tatipaka, SA McGuffin, NK Chennamaneni, M Karimi, J Arif, ...
Journal of medicinal chemistry 53 (10), 3887-3898, 2010
强制性开放获取政策： US National Institutes of Health
Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors
KK Ojo, C Pfander, NR Mueller, C Burstroem, ET Larson, CM Bryan, ...
The Journal of clinical investigation 122 (6), 2301-2305, 2012
强制性开放获取政策： US National Institutes of Health
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob
H Wang, YC Liaw, D Stone, O Kalyuzhniy, I Amiraslanov, S Tuve, ...
Journal of virology 81 (23), 12785-12792, 2007
强制性开放获取政策： German Research Foundation
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation.
KK Ojo, RT Eastman, R Vidadala, Z Zhang, KL Rivas, R Choi, JD Lutz, ...
The Journal of Infectious Diseases 209 (2), 275-284, 2014
强制性开放获取政策： US National Institutes of Health
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies
TL Arakaki, FS Buckner, JR Gillespie, NA Malmquist, MA Phillips, ...
Molecular microbiology 68 (1), 37-50, 2008
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei infection in mice
S Shibata, JR Gillespie, AM Kelley, AJ Napuli, Z Zhang, KV Kovzun, ...
Antimicrobial agents and chemotherapy 55 (5), 1982-1989, 2011
强制性开放获取政策： US National Institutes of Health
Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1
ET Larson, KK Ojo, RC Murphy, SM Johnson, Z Zhang, JE Kim, DJ Leibly, ...
Journal of Medicinal Chemistry 55 (6), 2803-2810, 2012
强制性开放获取政策： US National Institutes of Health
Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection
CY Koh, JE Kim, S Shibata, RM Ranade, M Yu, J Liu, JR Gillespie, ...
Structure 20 (10), 1681-1691, 2012
强制性开放获取政策： US National Institutes of Health
In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46
H Wang, Y Liu, ZY Li, S Tuve, D Stone, O Kalyushniy, D Shayakhmetov, ...
Journal of virology 82 (21), 10567-10579, 2008
强制性开放获取政策： US National Institutes of Health, German Research Foundation
Pharmacological Characterization, Structural Studies, and In Vivo Activities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib
FS Buckner, MT Bahia, PK Suryadevara, KL White, DM Shackleford, ...
Antimicrobial agents and chemotherapy 56 (9), 4914-4921, 2012
强制性开放获取政策： US National Institutes of Health, Government of Spain
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 ( Pf CDPK4) inhibitors that block the transmission of malaria to mosquitoes
RSR Vidadala, KK Ojo, SM Johnson, Z Zhang, SE Leonard, A Mitra, ...
European journal of medicinal chemistry 74, 562-573, 2014
强制性开放获取政策： US National Institutes of Health
Potent and Selective Inhibitors of CDPK1 from T. gondii and C. parvum Based on a 5-Aminopyrazole-4-carboxamide Scaffold
Z Zhang, KK Ojo, RSR Vidadala, W Huang, JA Geiger, S Scheele, R Choi, ...
ACS medicinal chemistry letters 5 (1), 40-44, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定